Dr. Viral Shah is a board-certified adult endocrinologist and associate professor at the Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus. His research is focused on improving glycemic control and reducing complications, with special interest in fracture prevention, in people with type 1 diabetes (T1D).
Dr. Shah has served as principal investigator on several clinical trials of diabetes technologies and therapeutics such as REPLACE BG, WISDM, Dexcom G6 pivotal study, and insulet’ OP5 HCL clinical trial. He has recently published recommendations on standardizing closed-loop system reporting to make these devices downloads easy for patients and providers to understand and optimize glycemic control.